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Abstract
Background: Encephalitis with antibodies against N-methyl D-aspartate receptor (NMDAR) is recognized as a group
of antibody-mediated neuropsychiatric syndromes, which occurs with and without a tumor association. Neoplasm
may contribute to the pathogenesis of Anti-NMDAR encephalitis in tumor-positive patients. However, the
underlying causes in tumor-negative patients are largely unknown. This is the first report, of which we are aware, of
two cases of anti-NMDAR encephalitis after the resection of melanocytic nevus.
Case presentation: We describe 2 female patients in their 20s confirmed with anti-NMDAR encephalitis. They
shared two points in common: About several weeks (2 weeks and 5 weeks respectively) before the initial symptom,
both of them underwent a resection of melanocytic nevi; the screening tests for an ovarian teratoma and other
tumors were all negative. A 25 year-old woman presented with seizure, psychiatric symptoms and behavioral
change for 2 weeks. Electroencephalogram indicated electrographic seizures. Anti-NMDAR antibodies were all
positive in the cerebrospinal fluid and serum. Her symptoms relieved gradually after the treatment with steroids
and mycophenolate mofetil. Another patient admitted to our hospital with psychosis, behavioral change and
complex partial seizure over a period of 5 months. Electroencephalogram demonstrated generalized slow activities.
High titres of anti-NMDAR antibodies were both detected in the cerebrospinal fluid and serum. She responded well
to the first-line immunotherapy and got substantial recovery.
Conclusion: Our cases provided an observational link between anti-NMDAR encephalitis and resection of nevi. We
postulate that the exposure of certain antigen on nevus cell caused by nevi excision, which might be NMDA
receptor or other mimic cross-reactive antigens, may trigger an autoimmune response resulting in encephalitis. This
suggested a potential site of antigen exposure triggering the immune response in non-tumor associated anti-NMDAR
encephalitis, which may lend support to elucidating the underlying immunopathological mechanisms. Further studies
are expected for investigating the expression of NMDA receptor on nevus cell and evaluating the validity of this
hypothesis.
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Background
Encephalitis with antibodies against N-methyl D-aspartate
receptor (NMDAR) is recognized as a group of antibody-
mediated neuropsychiatric syndromes, which occurs with
and without a tumor association. Neoplasm may contrib-
ute to the pathogenesis of anti-NMDAR encephalitis in
tumor-positive patients. Other evidence showed that
non-specific systemic infections or vaccinations could
act as an adjuvant of the autoimmune response.
However, the underlying causes in tumor-negative
patients are still largely unknown. This is the first report,
of which we are aware, of two cases of anti-NMDAR
encephalitis after the resection of melanocytic nevus.
Case presentation
Case 1
A 25 year-old woman presented with seizure, psychiatric
symptoms and behavioral change for 2 weeks. About
5 weeks before her first symptom, she underwent a
resection of nevi on her nose in a local hospital, of
which the pathological diagnosis is compound nevus
confirmed by the dermatologist. Her family history was
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unremarkable. The brain magnetic resonance imaging
(MRI) showed normal while the electroencephalogram
(EEG) indicated electrographic seizures. For her lumbar
puncture, the cerebrospinal fluid (CSF) white blood cell
(WBC) count was 2/μL; the CSF protein concentration,
54 mg/dl. The CSF-specific oligoclonal bands were weak
positive. The serum and CSF samples were tested for the
antibodies to cell-surface antigens including NMDAR,
leucine-rich glioma inactivated 1 (LGI1), contactin-
associated protein 2 (CASPR2), γ-amino-butyric acid-B
receptor (GABABR) and alpha-amino-3-hydroxy-5-me-
thyl-4-iso-xazolepropionic acid receptors (AMPAR), using
a commercial assay (Catalogue No. FA 112d-1003-1,
EUROIMMUN AG, Lübeck, Germany). Anti-NMDAR
antibodies were all positive in the CSF and serum. Screen-
ing with an ultrasonographic examination of her ovaries
and a computed tomographic scan of her chest, abdomen,
and pelvis showed no evidence of tumors. She received
methylprednisolone at a dose of 1 g per day for 5 days.
Steroids were tapered down gradually as her symptoms re-
lieved. Mycophenolate mofetil was added as the continued
immunotherapy. The follow-up is still going on.
Case 2
A girl in her 20s was admitted to our hospital with
psychosis, behavioral change and complex partial seizure
over a period of 5 months. A resection of nevus on her
forehead was performed about 2 weeks before her
admission, which was intradermal nevus on the histo-
pathology. The brain MRI was unremarkable and the
EEG demonstrated generalized slow activity. The CSF
analysis revealed the WBC count was 66/μL with 99
lymphocytes and 1 % monocytes, and the protein con-
centration level was 72 mg/dL. The same tests with serum
and CSF for available antibodies to cell-surface antigens
were performed as previously described. High titres of
anti-NMDAR antibodies were both detected in the CSF
and serum. The screening tests for an ovarian teratoma
and other tumors were all negative. She received one
course of intravenous immunoglobulin, 2 g/kg, divided
into 5 days, followed with intravenous methylprednisolone
at an initial dosage of 80 mg per day. Gradually, her
psychotic symptoms resolved and she was able to follow
simple commands and talk to her parents. The test for
NMDAR antibody in CSF became negative afterwards
while that in serum remained positive.
Discussion and conclusions
Anti-NMDAR encephalitis represents a characteristic
immune-mediated and treatment responsive neuropsychi-
atric syndrome, with and without a tumor association.
Dalmau et al. [1] reported the presence of an ovarian
teratoma in over 50 % of anti-NMDAR encephalitis
patients. The tumor that expresses NMDA receptors
may trigger the antibody response against NMDA recep-
tors by ectopically expressing neuronal antigens and
contribute to breaking immune tolerance [2, 3]. However,
they also indicated that 41 % of patients with anti-
NMDAR encephalitis do not have a clinically detectable
tumor. Therefore, the underlying causes in tumor-
negative patients are still largely unknown. Our cases
provided an observational link between anti-NMDAR
encephalitis and resection of nevi, which may provide
insights into the trigger factor of immune response in
non–tumor associated anti-NMDAR encephalitis.
NMDA receptors are a class of ionotropic glutamate
receptors (iGluRs) that are essential for neuronal develop-
ment, synaptic plasticity and cell survival. NMDA receptors
are obligate heterotetramers comprising of a combination
of NR1, the obligatory subunit for a functional receptor,
and structurally related NR2 subunits [4]. Studies have
demonstrated the NR1 subunit of NMDA receptor is also
expressed on human keratinocytes, using immunohis-
tochemistry [5, 6]. Hoogduijn et al. found that cultured
melanocytes express the NMDA receptors 2A and 2C [7].
Therefore, we postulate that the nevus cell may express
NMDA receptor or other mimic cross-reactive antigens
on the cell surface. Exposure of certain antigens caused by
nevi excision may trigger an autoimmune response and
generation of anti-NMDAR antibodies, resulting in
encephalitis. This suggested a potential site of antigen
exposure triggering the immune response in non-tumor
associated anti-NMDAR encephalitis, which may lend
support to elucidating the underlying immunopathological
mechanisms. Further studies were expected for investigat-
ing the expression of NMDA receptor on nevus cell and
evaluating the validity of this hypothesis.
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